UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply

Alimentary pharmacology & therapeutics, 2024-04, Vol.59 (8), p.1011-1011

2024

Volltextzugriff (PDF)

Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?

World journal of gastroenterology : WJG, 2017-09, Vol.23 (35), p.6385-6402

2017

Volltextzugriff (PDF)

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis

Biomedicines, 2023-05, Vol.11 (5), p.1408

2023

Volltextzugriff (PDF)

Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2019-09, Vol.25 (9), p.1462-1473

2019

Volltextzugriff (PDF)

Satisfaction with patient-doctor relationships in inflammatory bowel diseases：Examining patient-initiated change of specialist

World journal of gastroenterology : WJG, 2012-05, Vol.18 (18), p.2212-2218

2012

Volltextzugriff (PDF)

Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability

World journal of gastroenterology : WJG, 2020-09, Vol.26 (36), p.5437-5449

2020

Volltextzugriff (PDF)

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy

Intestinal research, 2022, 20(1), , pp.101-113

2022

Volltextzugriff (PDF)

Predicting response after infliximab salvage in acute severe ulcerative colitis

Journal of gastroenterology and hepatology, 2018-07, Vol.33 (7), p.1347-1352

2018

Volltextzugriff (PDF)

Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study

Journal of Crohn's and colitis, 2018-02, Vol.12 (3), p.289-297

2018

Volltextzugriff (PDF)

Intestinal Ultrasound in the Assessment of Luminal Crohn’s Disease

Gastrointestinal disorders (Basel, Switzerland), 2022-09, Vol.4 (4), p.249-262

2022

Volltextzugriff (PDF)

The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease

Therapeutic advances in gastroenterology, 2024-01, Vol.17, p.17562848241237895-17562848241237895

2024

Volltextzugriff (PDF)

Authors’ Response to Letter to Editor: “Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status”

Inflammatory bowel diseases, 2024-08, Vol.30 (8), p.1441-1441

2024

Volltextzugriff (PDF)

Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease

Diagnostics (Basel), 2022-10, Vol.12 (10), p.2533

2022

Volltextzugriff (PDF)

Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease

Inflammatory bowel diseases, 2013-12, Vol.19 (13), p.2906-2918

2013

Volltextzugriff (PDF)

Utility of panenteric capsule endoscopy for the detection of small‐bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study

JGH open, 2023-12, Vol.7 (12), p.966-973

2023

Volltextzugriff (PDF)

Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s disease

Intestinal research, 2024-04, Vol.22 (2), p.152-161

2024

Volltextzugriff (PDF)

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply

Alimentary pharmacology & therapeutics, 2024-03, Vol.59 (6), p.794-794

2024

Volltextzugriff (PDF)

A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy

Therapeutic advances in chronic disease, 2019, Vol.10, p.2040622319825595-2040622319825595

2019

Volltextzugriff (PDF)

Editorial: delving into the natural history of Crohn’s disease and the impact of medical therapy

Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (1), p.108-109

2022

Volltextzugriff (PDF)

Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study

World journal of gastroenterology : WJG, 2021-10, Vol.27 (38), p.6476-6488

2021

Volltextzugriff (PDF)

Editorial: does anti‐TNF “treatment persistence” always equate to “effective treatment”? Only objective disease assessments can answer the question

Alimentary pharmacology & therapeutics, 2021-09, Vol.54 (5), p.718-719

2021

Volltextzugriff (PDF)

Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses

Journal of gastroenterology and hepatology, 2023-05, Vol.38 (5), p.724-732

2023

Volltextzugriff (PDF)

Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis

Inflammatory bowel diseases, 2016-12, Vol.22 (12), p.2966-2976

2016

Volltextzugriff (PDF)

Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?

Inflammatory bowel diseases, 2024-03

2024

Volltextzugriff (PDF)

Letter: choosing between ustekinumab and vedolizumab in anti‐TNF refractory Crohn’s disease—the devil is in the detail

Alimentary pharmacology & therapeutics, 2020-08, Vol.52 (3), p.561-562

2020

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(98)

Publikationsform

Artikel
(113)
Buchkapitel
(1)

Sprache

Englisch
(114)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Letter: Thioguanine, an under‐utilised option in inflammatory bowel disease? Authors' reply

Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn's Disease: A Systematic Review and Meta-Analysis

Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease

Satisfaction with patient-doctor relationships in inflammatory bowel diseases：Examining patient-initiated change of specialist

Transitioning patients with inflammatory bowel disease from hospital-based to rapid home-based infliximab: A stepwise, safety and patient-orientated process towards sustainability

Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy

Predicting response after infliximab salvage in acute severe ulcerative colitis

Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study

Intestinal Ultrasound in the Assessment of Luminal Crohn’s Disease

The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease

Authors’ Response to Letter to Editor: “Evaluating Serum Free Thiols in Inflammatory Bowel Disease: Contribution of Albumin to Extracellular Free Thiol Status”

Challenges and Strategies to Optimising the Quality of Small Bowel Magnetic Resonance Imaging in Crohn’s Disease

Impact of ethnicity, geography, and disease on the microbiota in health and inflammatory bowel disease

Utility of panenteric capsule endoscopy for the detection of small‐bowel Crohn's disease in patients with a normal magnetic resonance enterography: A prospective observational pilot study

Assessing quality of magnetic resonance enterography and its impact on disease assessment of ileal Crohn’s disease

Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply

A comparison of long-term healthcare utilization and costs in patients with acute severe ulcerative colitis receiving infliximab versus early colectomy

Editorial: delving into the natural history of Crohn’s disease and the impact of medical therapy

Deep learning vs conventional learning algorithms for clinical prediction in Crohn's disease: A proof-of-concept study

Editorial: does anti‐TNF “treatment persistence” always equate to “effective treatment”? Only objective disease assessments can answer the question

Dose intensification strategy influences infliximab pharmacokinetics but not clinical response after the same number of doses

Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis

Prospective Evaluation of Serum Free Thiols in Inflammatory Bowel Disease: A Candidate to Replace C-Reactive Protein for Disease Activity Assessment?

Letter: choosing between ustekinumab and vedolizumab in anti‐TNF refractory Crohn’s disease—the devil is in the detail

Suchergebnisse filtern